These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16644086)

  • 1. Mirtazapine inhibits salivary cortisol concentrations in anorexia nervosa.
    Schüle C; Sighart C; Hennig J; Laakmann G
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1015-9. PubMed ID: 16644086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
    Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
    Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of mirtazapine on salivary cortisol in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S; Baccichet E; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects.
    Schüle C; Baghai T; Goy J; Bidlingmaier M; Strasburger C; Laakmann G
    Psychopharmacology (Berl); 2002 Aug; 163(1):95-101. PubMed ID: 12185405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of mirtazapine on urinary free cortisol excretion in depressed patients.
    Schule C; Baghai T; Rackwitz C; Laakmann G
    Psychiatry Res; 2003 Oct; 120(3):257-64. PubMed ID: 14561437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R
    Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in salivary cortisol levels as a prognostic predictor in children with anorexia nervosa.
    Shibuya I; Nagamitsu S; Okamura H; Komatsu H; Ozono S; Yamashita Y; Matsuishi T
    Int J Psychophysiol; 2011 Nov; 82(2):196-201. PubMed ID: 21906636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between alexithymia and salivary cortisol levels in somatoform disorders.
    Pedrosa Gil F; Bidlingmaier M; Ridout N; Scheidt CE; Caton S; Schoechlin C; Nickel M
    Nord J Psychiatry; 2008; 62(5):366-73. PubMed ID: 18752108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
    Pahwa R; Lyons KE
    Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
    Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
    Paslakis G; Luppa P; Gilles M; Kopf D; Hamann-Weber B; Lederbogen F; Deuschle M
    J Psychiatr Res; 2010 Jun; 44(8):556-60. PubMed ID: 20022345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment.
    Weber-Hamann B; Kratzsch J; Kopf D; Lederbogen F; Gilles M; Heuser I; Deuschle M
    J Psychiatr Res; 2007; 41(3-4):344-50. PubMed ID: 16497334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa.
    Monteleone P; Scognamiglio P; Canestrelli B; Serino I; Monteleone AM; Maj M
    Psychol Med; 2011 Sep; 41(9):1963-9. PubMed ID: 21284914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.